HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ying Li Selected Research

Cycloleucine

1/2022METTL3 inhibition ameliorates liver damage in mouse with hepatitis B virus-associated acute-on-chronic liver failure by regulating miR-146a-5p maturation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ying Li Research Topics

Disease

673Neoplasms (Cancer)
05/2024 - 04/2000
253Inflammation (Inflammations)
05/2024 - 05/2006
168Infections
04/2024 - 02/2004
108Hypertension (High Blood Pressure)
04/2024 - 08/2002
99Neoplasm Metastasis (Metastasis)
04/2024 - 02/2003
87Breast Neoplasms (Breast Cancer)
04/2024 - 03/2005
74Fibrosis (Cirrhosis)
04/2024 - 01/2007
74Insulin Resistance
01/2024 - 07/2004
74Type 2 Diabetes Mellitus (MODY)
11/2023 - 09/2007
72Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
04/2024 - 08/2008
70Lung Neoplasms (Lung Cancer)
05/2024 - 06/2008
69Pain (Aches)
04/2024 - 06/2009
68Wounds and Injuries (Trauma)
05/2024 - 03/2006
67Obesity
03/2024 - 05/2003
64Hypoxia (Hypoxemia)
04/2024 - 07/2009
62Body Weight (Weight, Body)
05/2024 - 05/2003
62Carcinogenesis
04/2024 - 04/2000
58Cardiovascular Diseases (Cardiovascular Disease)
05/2024 - 08/2002
56Stroke (Strokes)
05/2024 - 08/2002
54Hepatocellular Carcinoma (Hepatoma)
05/2024 - 06/2006
41COVID-19
04/2024 - 01/2020
40Alzheimer Disease (Alzheimer's Disease)
04/2024 - 05/2010
38Colorectal Neoplasms (Colorectal Cancer)
01/2024 - 10/2009
35Ischemic Stroke
05/2024 - 04/2006
33Diabetic Nephropathies (Diabetic Nephropathy)
04/2024 - 11/2007
33Atherosclerosis
01/2024 - 01/2007
33Stomach Neoplasms (Stomach Cancer)
01/2024 - 03/2006
32Heart Failure
05/2024 - 03/2012
32Prostatic Neoplasms (Prostate Cancer)
03/2024 - 05/2002
32Myocardial Infarction
01/2024 - 05/2009
31Cognitive Dysfunction
04/2024 - 10/2009
29Hemorrhage
05/2024 - 02/2003
29Adenocarcinoma of Lung
02/2024 - 05/2010
29Mitochondrial Diseases (Mitochondrial Disease)
02/2024 - 09/2010
28Hypersensitivity (Allergy)
04/2024 - 07/2005
28Ischemia
04/2024 - 04/2006
27Psoriasis (Pustulosis Palmaris et Plantaris)
04/2024 - 06/2014
27Leukemia
06/2023 - 03/2007
26Carcinoma (Carcinomatosis)
04/2024 - 04/2000
25Glioma (Gliomas)
04/2024 - 05/2014
25Reperfusion Injury
10/2023 - 01/2008
24Sepsis (Septicemia)
04/2024 - 06/2009
24Brain Ischemia (Cerebral Ischemia)
04/2024 - 05/2007
24Dry Eye Syndromes (Dry Eye Syndrome)
12/2023 - 01/2015
24Diarrhea
12/2023 - 01/2002
24Hyperglycemia
11/2023 - 05/2004
23Pancreatic Neoplasms (Pancreatic Cancer)
04/2024 - 01/2012
23Liver Cirrhosis (Hepatic Cirrhosis)
03/2024 - 08/2011
23Rhinosinusitis
01/2024 - 03/2012
23Necrosis
10/2023 - 08/2003

Drug/Important Bio-Agent (IBA)

279Proteins (Proteins, Gene)FDA Link
05/2024 - 04/2000
201Biomarkers (Surrogate Marker)IBA
05/2024 - 04/2000
107Glucose (Dextrose)FDA LinkGeneric
03/2024 - 08/2002
104CytokinesIBA
05/2024 - 06/2006
80MicroRNAs (MicroRNA)IBA
02/2024 - 09/2010
76Messenger RNA (mRNA)IBA
05/2024 - 05/2003
74LipidsIBA
05/2024 - 08/2006
67Therapeutic UsesIBA
04/2024 - 03/2006
56Long Noncoding RNAIBA
10/2023 - 01/2015
54RNA (Ribonucleic Acid)IBA
04/2024 - 01/2008
53DNA (Deoxyribonucleic Acid)IBA
05/2024 - 11/2002
49Reactive Oxygen Species (Oxygen Radicals)IBA
04/2024 - 10/2009
48EnzymesIBA
05/2024 - 07/2003
47Insulin (Novolin)FDA Link
01/2024 - 05/2003
45CholesterolIBA
01/2024 - 08/2002
42Interleukin-6 (Interleukin 6)IBA
03/2024 - 06/2006
42Triglycerides (Triacylglycerol)IBA
03/2024 - 03/2004
42Phosphotransferases (Kinase)IBA
02/2024 - 03/2002
40Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
03/2024 - 08/2003
37LigandsIBA
04/2024 - 07/2008
37Peptides (Polypeptides)IBA
01/2024 - 03/2002
36Blood Glucose (Blood Sugar)IBA
01/2024 - 04/2004
35Indicators and Reagents (Reagents)IBA
03/2024 - 01/2011
34CollagenIBA
05/2024 - 11/2006
34salicylhydroxamic acid (SHAM)IBA
02/2024 - 06/2009
33AntioxidantsIBA
05/2024 - 02/2012
33AntigensIBA
04/2024 - 03/2002
32Small Interfering RNA (siRNA)IBA
04/2024 - 05/2010
30Anti-Bacterial Agents (Antibiotics)IBA
02/2024 - 02/2012
28ErbB Receptors (EGF Receptor)IBA
05/2024 - 08/2005
28VaccinesIBA
03/2024 - 03/2002
28Transcription Factors (Transcription Factor)IBA
12/2023 - 04/2008
28Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
02/2023 - 06/2007
26Circular RNAIBA
05/2024 - 01/2017
26CalciumIBA
03/2024 - 01/2005
26CateninsIBA
12/2023 - 08/2015
25LipopolysaccharidesIBA
03/2024 - 07/2009
24Tyrosine Kinase InhibitorsIBA
05/2024 - 12/2009
24Retinaldehyde (Retinal)IBA
04/2024 - 06/2009
24Doxorubicin (Adriamycin)FDA LinkGeneric
04/2024 - 03/2005
23Antiviral Agents (Antivirals)IBA
01/2024 - 05/2007

Therapy/Procedure

374Therapeutics
12/2024 - 08/2002
100Drug Therapy (Chemotherapy)
05/2024 - 04/2008
50Immunotherapy
05/2024 - 06/2006
45Transplantation
02/2024 - 10/2003
41Radiotherapy
02/2024 - 08/2005
30Chinese Traditional Medicine (Traditional Chinese Medicine)
01/2024 - 11/2007
27Acupuncture Points (Acupuncture Point)
02/2024 - 10/2008
27Aftercare (After-Treatment)
01/2024 - 06/2009
25Lasers (Laser)
04/2024 - 05/2007